Results 161 to 170 of about 46,834 (302)
Racial disparities in anaemia associated with paediatric chronic kidney disease
British Journal of Haematology, EarlyView.
Manya Raina +3 more
wiley +1 more source
ABSTRACT Background Hemodialysis access thrombosis is the primary cause of access failure. Thrombus removal is an effective strategy to restore access function. Although both open surgical and endovascular procedures enable thrombus clearance, endovascular thrombus reduction therapy is widely adopted in clinical practice for this condition due to its ...
Lin Li +5 more
wiley +1 more source
ABSTRACT Background Uremic pruritus (UP) remains a common and distressing complication in patients with end‐stage renal disease (ESRD) receiving maintenance hemodialysis. The burden is particularly pronounced in low‐ and middle‐income countries where twice‐weekly hemodialysis is frequently practiced because of resource limitations. Gabapentin is widely
Bilal Mohsin +9 more
wiley +1 more source
Evaluating Darbepoetin Treatment Strategies for Managing Anaemia in Haemodialysis Patients: Effects on All-Cause Mortality From a Target Trial Emulation Using Electronic Health Record Data. [PDF]
Birnie K +6 more
europepmc +1 more source
Abstract Background Management of Staphylococcus aureus bacteraemia (SAB) requires prolonged intravenous (IV) antibiotic therapy delivered in hospital or through Hospital in the Home (HITH), often requiring peripherally inserted central catheters (PICCs) and substantial healthcare resources.
Eli Dunn +3 more
wiley +1 more source
CKD-Associated Pruritus in Home Haemodialysis: A Signal for Routine Symptom Surveillance Rather Than a Severity Gradient. [PDF]
Wu M, Jin J, He Q.
europepmc +1 more source
Abstract Background Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous tigecycline in patients who are progressing to fulminant infection.
Emma Bishop +5 more
wiley +1 more source
Once-weekly erythropoiesis-stimulating agent dosing and haemoglobin outcomes in maintenance haemodialysis: a single-centre evaluation. [PDF]
Tseng CI +6 more
europepmc +1 more source
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) are major causes of morbidity and mortality in people with type 2 diabetes (T2D). Contemporary CKD guidelines increasingly support incorporation of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) as an additional pillar of cardiorenal therapy alongside renin–angiotensin ...
Eugenia Pedagogos +5 more
wiley +1 more source
Blood Glucose Management Behaviour Among Haemodialysis Patients with Diabetes: A Qualitative Study Guided by the Theory of Planned Behaviour. [PDF]
Wang L +6 more
europepmc +1 more source

